
|Videos|December 10, 2020
Controlling postop pain, inflammation in cataract patients: drug delivery vs drops
Author(s)Alex Delaney-Gesing , David Hutton
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
Advertisement
John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
AI-predicted retinal function shows promise in geographic atrophy
2
Mulling over options for mitigating severe vision loss from diabetes
3
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
4
Trehalose-hyaluronate combination aids tear film after eyelid surgery
5






















